Navidea Biopharmaceuticals (NAVB) May Double in 2013

Although shares of Navidea Biopharmaceuticals Inc (NYSEAMEX:NAVB) are relatively unchanged over the trailing-12-month period, ask shareholders and they'd probably consider Navidea...

Keep Reading →